Australia Digestive System Disorder Medicine Sales is set to reach $1,030 Million by 2026 from $1,020 Million, is expected to fall by 0.3% per year. Since 2017, the market increased 3.9% year on year at $36,680 Million. Japan, South Korea and Canada respectively came in numbers 2, 3 and 4 in this ranking.
How does Australia perform in Digestive System Disorder?
Forecast: Alimentary Tract and Metabolism Medicine Sales in Australia
- Million Australian Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Australia
- Million Australian Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Australia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Australia
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Australia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Australia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Australia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Australia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Australia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Australia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research